CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1704.80-22.9 (-1.33 %)
PREV CLOSE () 1727.70
OPEN PRICE () 1730.00
BID PRICE (QTY) 1704.90 (10)
OFFER PRICE (QTY) 1706.05 (26)
VOLUME 33313
TODAY'S LOW / HIGH ()1704.80 1732.80
52 WK LOW / HIGH ()1555 1960.2
NSE1707.50-20 (-1.16 %)
PREV CLOSE() 1727.50
OPEN PRICE () 1730.00
BID PRICE (QTY) 1707.40 (1)
OFFER PRICE (QTY) 1707.50 (15)
VOLUME 1393860
TODAY'S LOW / HIGH() 1704.20 1731.30
52 WK LOW / HIGH ()1553.05 1960.35
ChairmanDilip S Shanghvi
Managing DirectorDilip S Shanghvi
Company SecretaryAnoop Deshpande
Non Executive Independent DirectorRolf Hoffmann
Gautam Doshi
Rama Bijapurkar
Whole Time DirectorAalok Shanghvi
Vidhi Shanghvi
Non Independent & Non Executive DirectorSudhir V Valia
Lead Independent DirectorPawan Goenka
Incorporation Year : 01-03 1993

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja, Vadodara,
Gujarat-390012 .

Phone : 0265- 5515500 / 5515600 / 5515700

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX82630.5359.62 (0.07%)
NIFTY25216.7020.90 (0.08%)
Dow Jones 44023.29-436.36 (-0.98%)
Nasdaq 20677.8037.47 (0.18%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI